UBE2T and cancer: In concordance with our finding, previous studies on UBE2T reported upregulation of UBE2T in many cancer types, such as liver, prostate, lung, nasopharyngeal, and gastric cancer12,16,20–22, and UBE2T overexpression has been demonstrated to be related to cell proliferation, migration and invasion, and drug resistance11,20,23.